An essential prenatal test that checks for specific chromosomal disorders, such as neural tube abnormalities and Down syndrome, is the HHD Triple Marker Panel. The AFP, hCG, and estriol levels in the pregnant woman’s blood are measured by this panel. The HHD Triple Marker Panel aids in the early detection of any genetic problems by offering a risk assessment during the second trimester of pregnancy. This enables expectant parents to decide on additional diagnostic testing and care with knowledge. This panel is a crucial component of prenatal treatment because of HHD’s thorough approach and professional analysis, which provide peace of mind and support positive pregnancy outcomes.